We Can Medicines Co., Ltd. (TPEX:6929)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.35
+0.95 (4.24%)
Aug 20, 2026, 11:13 AM CST

We Can Medicines Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
223.72245.36305.67160.53216.26203.36
Trading Asset Securities
-40.39----
Cash & Short-Term Investments
223.72285.75305.67160.53216.26203.36
Cash Growth
-25.33%-6.52%90.42%-25.77%6.34%-24.73%
Accounts Receivable
200.11192.69178.05225.54142127.47
Other Receivables
35.5243.1940.7540.0527.9826.08
Receivables
235.63235.89218.8265.59169.98153.55
Inventory
838.64845.97850.88776.83690.45583.97
Prepaid Expenses
48.0280.6287.8287.9675.7952.49
Other Current Assets
0.971.451.450.632.161.55
Total Current Assets
1,3471,4501,4651,2921,155994.92
Property, Plant & Equipment
1,3721,4731,5621,5151,3701,150
Other Intangible Assets
3.74.336.953.874.979.38
Long-Term Deferred Tax Assets
0.510.510.530.61.1916.82
Other Long-Term Assets
50.3351.1751.3850.2244.939.13
Total Assets
2,8072,9783,0862,8612,5762,210

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
491.03512.31507.36540.01517.49443.55
Accrued Expenses
-22.9123.0221.4617.3516.66
Short-Term Debt
---135--
Current Portion of Long-Term Debt
7.387.37.147.076.25-
Current Portion of Leases
247.32252.91233.38210.29198.68173.38
Current Income Taxes Payable
---4.935.44-
Current Unearned Revenue
13.029.098.237.4410.8712.5
Other Current Liabilities
138.62143.34142.25118.9144.27130.02
Total Current Liabilities
897.38947.86921.391,045900.34776.11
Long-Term Debt
129.62133.33130.63137.71143.75150
Long-Term Leases
726.21803.81870.13826.51708.58567.47
Pension & Post-Retirement Benefits
5.625.625.793.934.387.93
Other Long-Term Liabilities
40.3339.1641.531.2627.0924.17
Total Liabilities
1,7991,9301,9692,0451,7841,526

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
450.9450.68448.54400400400
Additional Paid-In Capital
669.92669.76664.79353.53343.55339.45
Retained Earnings
-96.3-72.41.1962.8248.14-54.91
Comprehensive Income & Other
-16.210.411.65---
Shareholders' Equity
1,0081,0481,116816.35791.69684.54
Total Liabilities & Equity
2,8072,9783,0862,8612,5762,210

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,1111,1971,2411,3171,057890.85
Net Cash (Debt)
-886.81-911.59-935.62-1,156-841-687.49
Net Cash Growth
------
Net Cash Per Share
-19.78-20.26-21.53-27.36-20.16-17.19
Filing Date Shares Outstanding
44.6645.0744.85404040
Total Common Shares Outstanding
44.6645.0744.85404040
Working Capital
449.58501.81543.24246.44254.29218.81
Book Value Per Share
22.5823.2624.8820.4119.7917.11
Tangible Book Value
1,0051,0441,109812.48786.72675.16
Tangible Book Value Per Share
22.5023.1724.7320.3119.6716.88
Land
-217.03217.03217.03217.03217.03
Buildings
-76.4976.4976.4976.4976.49
Machinery
-27.1930.0227.6229.1421.67
Construction In Progress
-3.620.684.42.493.5
Leasehold Improvements
-376.56387.76345.44304.32232.24